Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Intercept Pharma (ICPT)
NASDAQ:ICPT
Intercept Pharma (ICPT) Stock Price & Analysis
1,441 Followers
ICPT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$8.82 - $21.86
Previous Close$11.19
Volume715.80K
Average Volume (3M)1.18M
Market Cap
$467.31M
Enterprise Value$1.11B
Total Cash (Recent Filing)$63.02M
Total Debt (Recent Filing)$705.23M
Price to Earnings (P/E)1.8
Beta1.20
Next Earnings
Aug 03, 2023EPS Estimate
-$0.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.35
Shares Outstanding41,687,084
10 Day Avg. Volume2,376,772
30 Day Avg. Volume1,175,997
Standard Deviation0.22
R-Squared0.10
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)6.54
Price to Sales (P/S)6.86
Price to Cash Flow (P/CF)-2.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.76
Enterprise Value/Gross Profit3.89
Enterprise Value/Ebitda-7.07
Forecast
1Y Price Target
$18.67Price Target Upside66.55% Upside
Rating ConsensusHold
Number of Analyst Covering12
Intercept Pharma News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ICPT FAQ
What was Intercept Pharma’s price range in the past 12 months?
Intercept Pharma lowest stock price was $8.82 and its highest was $21.86 in the past 12 months.
What is Intercept Pharma’s market cap?
Currently, no data Available
When is Intercept Pharma’s upcoming earnings report date?
Intercept Pharma’s upcoming earnings report date is Aug 03, 2023 which is in 58 days.
How were Intercept Pharma’s earnings last quarter?
Intercept Pharma released its earnings results on Apr 27, 2023. The company reported -$0.77 earnings per share for the quarter, missing the consensus estimate of -$0.647 by -$0.123.
Is Intercept Pharma overvalued?
According to Wall Street analysts Intercept Pharma’s price is currently Undervalued.
Does Intercept Pharma pay dividends?
Intercept Pharma does not currently pay dividends.
What is Intercept Pharma’s EPS estimate?
Intercept Pharma’s EPS estimate is -$0.55.
How many shares outstanding does Intercept Pharma have?
Intercept Pharma has 41,687,084 shares outstanding.
What happened to Intercept Pharma’s price movement after its last earnings report?
Intercept Pharma reported an EPS of -$0.77 in its last earnings report, missing expectations of -$0.647. Following the earnings report the stock price went down -12.923%.
Which hedge fund is a major shareholder of Intercept Pharma?
Among the largest hedge funds holding Intercept Pharma’s share is Caxton Associates LP. It holds Intercept Pharma’s shares valued at 1M.
---
Intercept Pharma Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$18.67 (66.55% Upside)
$18.67 (66.55% Upside)
Blogger Sentiment
Neutral
ICPT Sentiment 50%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 8.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.1%
Last 30 Days ▲ 7.6%
Last 30 Days ▲ 7.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.68%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
0.14%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Intercept Pharma
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.
---
Top 5 ETFs holding ICPT
Vanguard Health Care ETF
$2.13M
iShares Core S&P Total U.S. Stock Market ETF
$556.33K
iShares NASDAQ US Biotechnology UCITS ETF
$214.73K
Fidelity MSCI Health Care Index ETF
$210.87K
iShares Russell 3000 ETF
$90.08K
Up to five ETFs with an Outperform Smart Score that hold ICPT. The ETFs are listed according to market value of ICPT within the ETF
---
Aurinia Pharmaceuticals
―
Corbus Pharmaceuticals
―
Enanta Pharmaceuticals
―
Galapagos
―
---